133 related articles for article (PubMed ID: 31255972)
1. Maltase-glucoamylase inhibition potency and cytotoxicity of pyrimidine-fused compounds: An in silico and in vitro approach.
Mehraban MH; Mansourian M; Ahrari S; HajiEbrahimi A; Odooli S; Motovali-Bashi M; Yousefi R; Ghasemi Y
Comput Biol Chem; 2019 Oct; 82():25-36. PubMed ID: 31255972
[TBL] [Abstract][Full Text] [Related]
2. Mammalian maltase-glucoamylase and sucrase-isomaltase inhibitory effects of Artocarpus heterophyllus: An in vitro and in silico approach.
Abdulhaniff P; Sakayanathan P; Loganathan C; Iruthayaraj A; Thiyagarajan R; Thayumanavan P
Comput Biol Chem; 2024 Jun; 110():108052. PubMed ID: 38492557
[TBL] [Abstract][Full Text] [Related]
3. Morning glory resin glycosides as α-glucosidase inhibitors: In vitro and in silico analysis.
Rosas-Ramírez D; Escandón-Rivera S; Pereda-Miranda R
Phytochemistry; 2018 Apr; 148():39-47. PubMed ID: 29421509
[TBL] [Abstract][Full Text] [Related]
4. Probing the binding of Syzygium-derived α-glucosidase inhibitors with N- and C-terminal human maltase glucoamylase by docking and molecular dynamics simulation.
Roy D; Kumar V; Acharya KK; Thirumurugan K
Appl Biochem Biotechnol; 2014 Jan; 172(1):102-14. PubMed ID: 24046257
[TBL] [Abstract][Full Text] [Related]
5. Luminal starch substrate "brake" on maltase-glucoamylase activity is located within the glucoamylase subunit.
Quezada-Calvillo R; Sim L; Ao Z; Hamaker BR; Quaroni A; Brayer GD; Sterchi EE; Robayo-Torres CC; Rose DR; Nichols BL
J Nutr; 2008 Apr; 138(4):685-92. PubMed ID: 18356321
[TBL] [Abstract][Full Text] [Related]
6. Modeling of cooked starch digestion process using recombinant human pancreatic α-amylase and maltase-glucoamylase for in vitro evaluation of α-glucosidase inhibitors.
Cao X; Zhang C; Dong Y; Geng P; Bai F; Bai G
Carbohydr Res; 2015 Sep; 414():15-21. PubMed ID: 26162745
[TBL] [Abstract][Full Text] [Related]
7. Structural insight into substrate specificity of human intestinal maltase-glucoamylase.
Ren L; Qin X; Cao X; Wang L; Bai F; Bai G; Shen Y
Protein Cell; 2011 Oct; 2(10):827-36. PubMed ID: 22058037
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the Enzymatic Profile of Mulberry Alkaloids by Enzymatic Study and Molecular Docking.
Liu Z; Yang Y; Dong W; Liu Q; Wang R; Pang J; Xia X; Zhu X; Liu S; Shen Z; Xiao Z; Liu Y
Molecules; 2019 May; 24(9):. PubMed ID: 31071910
[TBL] [Abstract][Full Text] [Related]
9. Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.
Suresh L; Onkara P; Kumar PS; Pydisetty Y; Chandramouli GV
Bioorg Med Chem Lett; 2016 Aug; 26(16):4007-14. PubMed ID: 27406797
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and inhibition kinetics of α-glucosidase activity by labdane diterpenes isolated from tora seeds (Alpinia nigra B.L. Burtt.).
Ghosh S; Rangan L
Appl Biochem Biotechnol; 2015 Feb; 175(3):1477-89. PubMed ID: 25410799
[TBL] [Abstract][Full Text] [Related]
11. Repurposing phytochemicals of
Sahu P; Sahoo R; Sahu AK; Saluja SS; Behera B
J Biomol Struct Dyn; 2024 Jul; 42(10):5197-5206. PubMed ID: 37350097
[TBL] [Abstract][Full Text] [Related]
12. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.
Proença C; Freitas M; Ribeiro D; Oliveira EFT; Sousa JLC; Tomé SM; Ramos MJ; Silva AMS; Fernandes PA; Fernandes E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1216-1228. PubMed ID: 28933564
[TBL] [Abstract][Full Text] [Related]
13. Binding study of novel anti-diabetic pyrimidine fused heterocycles to β-lactoglobulin as a carrier protein.
Mehraban MH; Yousefi R; Taheri-Kafrani A; Panahi F; Khalafi-Nezhad A
Colloids Surf B Biointerfaces; 2013 Dec; 112():374-9. PubMed ID: 24028850
[TBL] [Abstract][Full Text] [Related]
14. Dietary Flavonoids and Acarbose Synergistically Inhibit α-Glucosidase and Lower Postprandial Blood Glucose.
Zhang BW; Li X; Sun WL; Xing Y; Xiu ZL; Zhuang CL; Dong YS
J Agric Food Chem; 2017 Sep; 65(38):8319-8330. PubMed ID: 28875706
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study.
Laoud A; Ferkous F; Maccari L; Maccari G; Saihi Y; Kraim K
Comput Biol Chem; 2018 Feb; 72():122-135. PubMed ID: 29274684
[TBL] [Abstract][Full Text] [Related]
16. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
Dhameja M; Gupta P
Eur J Med Chem; 2019 Aug; 176():343-377. PubMed ID: 31112894
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity.
Sim L; Quezada-Calvillo R; Sterchi EE; Nichols BL; Rose DR
J Mol Biol; 2008 Jan; 375(3):782-92. PubMed ID: 18036614
[TBL] [Abstract][Full Text] [Related]
18. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
19. Spectroscopy and molecular docking analysis reveal structural specificity of flavonoids in the inhibition of α-glucosidase activity.
Liu JL; Kong YC; Miao JY; Mei XY; Wu SY; Yan YC; Cao XY
Int J Biol Macromol; 2020 Jun; 152():981-989. PubMed ID: 31765755
[TBL] [Abstract][Full Text] [Related]
20. Dietary 5,6,7-Trihydroxy-flavonoid Aglycones and 1-Deoxynojirimycin Synergistically Inhibit the Recombinant Maltase-Glucoamylase Subunit of α-Glucosidase and Lower Postprandial Blood Glucose.
Dong YS; Yu N; Li X; Zhang B; Xing Y; Zhuang C; Xiu ZL
J Agric Food Chem; 2020 Aug; 68(33):8774-8787. PubMed ID: 32806121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
